Evidence map›Paper›PMID 29416596›Full record

ArticleOncotarget2018

Urine anti-PLA2R antibody is a novel biomarker of idiopathic membranous nephropathy.

Yu Wang, Yi-Xin He, Tian-Tian Diao, Shi-Yao Wei, Wen-Rui Qi, Cen-Cen Wang, Shu-Min Song, Min Bi, Chun-Mei Li, Cai-Xia Zhang and 3 more

Open access · diamondAbstract read
In one paragraph

Article in Oncotarget, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
0.7field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it, 11 citations in OpenAlex.

  1. PLA2R autoantibodies, a multifaceted biomarker in nephrotic syndrome and membranous nephropathy.Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association · 2025
    Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 2 countries.

Yu WangDepartment of Nephrology, Second Affiliated Hospital of Harbin Medical University, Harbin, People's Republic of China.
Yi-Xin HeDepartment of Nephrology, Second Affiliated Hospital of Harbin Medical University, Harbin, People's Republic of China.
Tian-Tian DiaoDepartment of Nephrology, Second Affiliated Hospital of Harbin Medical University, Harbin, People's Republic of China.
Shi-Yao WeiDepartment of Nephrology, Second Affiliated Hospital of Harbin Medical University, Harbin, People's Republic of China.
Wen-Rui QiScience and Technology Department, Financial Mathematics Major, Beijing Normal University, Hong Kong Baptist University United International College, Zhuhai, People's Republic of China.
Cen-Cen WangDepartment of Nephrology, Second Affiliated Hospital of Harbin Medical University, Harbin, People's Republic of China.
Shu-Min SongDepartment of Nephrology, Second Affiliated Hospital of Harbin Medical University, Harbin, People's Republic of China.
Min BiDepartment of Nephrology, Second Affiliated Hospital of Harbin Medical University, Harbin, People's Republic of China.
Chun-Mei LiDepartment of Nephrology, Second Affiliated Hospital of Harbin Medical University, Harbin, People's Republic of China.
Cai-Xia ZhangDepartment of Nephrology, Second Affiliated Hospital of Harbin Medical University, Harbin, People's Republic of China.
Yan-Pei HouDepartment of Nephrology, Second Affiliated Hospital of Harbin Medical University, Harbin, People's Republic of China.
Qiu-Ju WeiDepartment of Nephrology, Second Affiliated Hospital of Harbin Medical University, Harbin, People's Republic of China.
Bing LiDepartment of Nephrology, Second Affiliated Hospital of Harbin Medical University, Harbin, People's Republic of China.
Harbin Medical University · CNSecond Affiliated Hospital of Harbin Medical University · CNBeijing Normal University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Since urine samples more directly reflect kidney alterations and damage than blood samples, we investigated whether urine anti-PLA

Indexed as

biomarkerdiagnosisidiopathic membranous nephropathyImmune responseImmunologyImmunology and Microbiology Sectionproteinuriaurine anti-PLA2R antibody

Identifiers

PMID29416596
PMCPMC5787499
OpenAlexW2742770841

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.